Pridopidine, ANAVEX2-73, SA4503, S1RA, and T-817MA (Table 1) are five drugs with Sig-1R ligand properties currently in clinical trials and showing significant results for pain, neurodegenerative diseases, depression, and ischemic stroke [207]. Here, SIGMAR1 is linked to depressive disorder.